Prostate Cancer Treatment at CMN Hospital

Advanced Inpatient Cancer Treatment

Prostate cancer can develop slowly, but the decisions surrounding care can still feel overwhelming. Many men who come to CMN Hospital have already undergone surgery, radiation, hormone therapy, chemotherapy, immunotherapy, targeted therapies, or other treatments before arriving. Others are newly diagnosed and searching for a more organized inpatient approach to care.

Prostate cancer may affect urinary health, hormone balance, inflammation, immune function, physical strength, energy, and overall quality of life. By the time many patients arrive, they may feel physically depleted from prior treatment, emotionally tired from difficult decisions, or concerned about recurrence, progression, or rising PSA levels.

At CMN Hospital, Dr. Edgar Payán reviews each patient’s diagnosis, imaging, pathology, PSA history, prior treatments, lab work, current symptoms, and overall condition before creating an individualized inpatient plan. Therapies are selected and adjusted throughout care based on the patient’s response during the program.

Why Men Seek Additional Options

Recurrence, Rising PSA, Hormone Resistance, and Treatment Fatigue

Some men begin searching for additional care after PSA levels continue rising, cancer returns after prior treatment, or hormone therapy is no longer producing the response they had hoped for. Others are concerned about the physical strain of repeated treatment and want care that also addresses strength, nutrition, immune function, and recovery during the inpatient stay.

Inside Dr. Payán’s 28-day inpatient program, care is brought together within one hospital environment. Therapies, laboratory services, meals, medical evaluations, and daily care are coordinated around the patient so he can focus more fully on rest, treatment, and recovery.

Therapies Used Within the Program

Immune Function, Oxygenation, Nutrition, and Recovery Support

Depending on the patient’s diagnosis, condition, and treatment history, care may include dendritic cell therapy, autologous bone marrow stem cell therapy, IV nutrient therapy, Hyperbaric Oxygen Therapy, Ultraviolet Blood Irradiation, Major Autohemotherapy ozone therapy, laboratory monitoring, nutritional care, and additional therapies selected by Dr. Payán during the inpatient program.

Treatment plans are individualized and may be adjusted throughout the stay based on lab results, symptoms, strength, tolerance, and clinical response during care.